Boris Sepesi MD FACS
@BorisSepesi
Followers
258
Following
91
Media
3
Statuses
70
Thoracic Surgery, Lung Cancer, Esophageal Cancer, Mesothelioma
Joined September 2022
RT @ValaAfshar: Life lessons from @rogerfederer (must watch). 1 Effortless is a myth.2 Belief in yourself has to be earned.3 Grit > Gift .4….
0
7K
0
RT @maraantonoff: I’m so proud of our @MDAndersonNews CT Surgery Jeopardy finalists, Drs @KGMitchellMD and @DavidNelsonMD! Come cheer for t….
0
3
0
RT @maraantonoff: I am one proud program director today! Our @MDAndersonNews thoracic surgery fellows, Drs @KGMitchellMD and @DavidNelsonMD….
0
8
0
RT @esinghimd: 🎉 12 days till 2023. ‼️ Quick 2022 snapshot review of @FDAOncology treatment approvals for our patients with lung cancer 👇🏽….
0
32
0
RT @VivekSubbiah: ⭐️Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors @NaturePortf….
0
45
0
RT @BrendonStilesMD: Indeed. Complete response from crowd who loved and benefited from the tag team talk!.
0
3
0
RT @DoctorJSpicer: To all thoracic surgeons: Have faith in your #medonc colleagues and witness the impact of neoadj chemoIO on QOL! @STS_CT….
0
2
0
RT @HSaterMD: Dr Tina Cascone @MDAndersonNews presented an amazing review of NIO in lung cancer #LCSM and highlighted NeoCoast Study. She a….
0
5
0
RT @AATSJournals: Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with #NSCLC. Read the full #JTCVS….
0
9
0
RT @MARIANOPROVENCI: NADIM II suggests PFS, OS benefits of nivolumab + chemo in resectable NSCLC - #GoogleAlerts.
mims.com
NADIM II suggests PFS, OS benefits of nivolumab + chemo in resectable NSCLC | MIMS Malaysia
0
4
0
RT @DrSteveMartin: @StephenVLiu @benlevylungdoc Just adding some more arguments to appeal to an international audience😉 .
0
6
0
RT @ShandaBlackmon: Looking forward to telling the story of why I wear pearls in the OR at GRIT tomorrow #GRIT2022 @MayoClinic @MayoClinicS….
0
11
0
RT @rjmehran: MD Anderson was honored with the presence of Dr. David Harpole from Duke University for the @MDAndersonNews 2022 Jack A. Roth….
0
8
0
RT @mtmdphd: Perioperative Therapy in Early-Stage Lung Cancer [July 28, 2022] @ADesaiMD @AnaVManana @JackWestMD @JAMAOnc Patient Page https….
0
10
0
RT @BrendonStilesMD: 1)The only thing in your power is preparation.2)Be suspicious of brilliance.3)Be appropriately respectful of authority….
0
6
0
RT @TEDTalks: When you stop being a jerk to yourself, you won't be the only one who benefits — *all* of your relationships will too! . Wat….
0
68
0
RT @DoctorJSpicer: Adjuvant atezo in my mind is for incidental pathological stage II or III disease w/ PDL1>50% found post resection in pat….
0
11
0
RT @FordePatrick: Interesting, immunotherapy first is better than targeted therapy for BRAF V600 melanoma. I would not be surprised if the….
lombardi.georgetown.edu
The findings, coupled with results from another recent clinical trial, mark significant advances in the treatment of melanoma. WASHINGTON (September 27, 2022) — A clinical trial led by clinicians at...
0
17
0